Treatment
Treatment A clinical trials
We’re tracking 8,310 recruiting studies that include Treatment A, each written for real people, not researchers, below.
Recruiting studies
- NCT04254354Recruiting
Body identity clinic for transgender men on testosterone
This trial is for transgender men who want care focused on body identity. It likely studies how testosterone treatment and clinic support affect body-related feelings and wellbeing.
OdenseAges 18 years+ - NCT05973214Recruiting
Program for thinking and coping in environmental intolerance
This trial tests whether a cognitive and behavioral therapy program can help adults with idiopathic environmental intolerance (IEI) manage symptoms and cope better. It may help by teaching practical ways of thinking and behaving when symptoms are triggered.
Paris, ParisAges 18 years+ - NCT06344572Recruiting
Study of SAT-001 for children with nearsightedness
This trial tests a device called SAT-001 to slow down nearsightedness (myopia) in children aged 5 to 9. It might help if your child has mild to moderate nearsightedness with low astigmatism.
IncheonAges 5–8 - NCT03765177RecruitingPhase 1/Phase 2
CLIC-1901 for CD19-positive blood and lymphoma cancers
This trial studies a gene-modified cell treatment called CLIC-1901 for people whose CD19-positive cancer has come back or did not respond to prior treatment. It may help shrink the cancer by targeting a protein called CD19 on cancer cells.
Vancouver, British ColumbiaAges 18–75 - NCT06075264RecruitingPhase 2
Artesunate ointment for high-grade vulvar lesions
This trial tests an artesunate ointment for women with high-grade vulvar lesions caused by HPV. It aims to see if the ointment can help the lesions heal or disappear without needing surgery.
Fort Myers, FloridaAges 18 years+ - NCT06177301RecruitingPhase 3
Comparing two drug combos for recurrent nasopharyngeal cancer
This study compares two combinations of drugs (tislelizumab plus either GX or GP) to see which works better for people with nasopharyngeal cancer that has returned or spread and has not been treated with systemic therapy before.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT05935722Recruiting
Home parenting support for parents of young children
This study tests a home-based parenting support program designed for parents who have learning or attention differences (like autism or ADHD). It aims to give tailored strategies to help you manage parenting daily challenges for children aged 0 to 9.
EnköpingAges Any age - NCT06650553Recruiting
Cord blood stem cell transplant for aplastic anemia
This study tests whether adding umbilical cord blood to a stem cell transplant from a half-matched donor can improve outcomes for people with severe aplastic anemia or related bone marrow failure diseases.
Taiyuan, ShanxiAges 6–75 - NCT06669806Recruiting
TIPS Stent Graft for Cirrhosis Complications
This study tests a TIPS stent graft (a tiny mesh tube placed in the liver to relieve pressure) for people with cirrhosis and complications like bleeding or fluid buildup. It aims to see how well it works and if it's safe.
Changsha, HunanAges 18–75 - NCT06675955RecruitingPhase 3
Extension study to keep taking ocrelizumab for multiple sclerosis
This extension study continues treatment with ocrelizumab for people with multiple sclerosis who are already taking it as part of a parent trial, to see how MS affects physical function over a longer time. It helps ensure you can keep receiving ocrelizumab even if it's not available where you live.
Amiens Cedex1Ages 18 years+ - NCT06681012Recruiting
Gelsectan for irritable bowel syndrome with diarrhea
This trial tests a supplement called Gelsectan to see if it reduces diarrhea and belly pain in people with diarrhea-predominant irritable bowel syndrome (IBS-D). It may help if you have loose, urgent stools more often than not.
LeuvenAges 18–65 - NCT06678984RecruitingPhase 3
Comparing two sling materials for stress urinary incontinence
This trial compares two surgical methods to treat stress urinary incontinence in women. One uses a graft made from donated umbilical vein tissue, and the other uses your own tissue (fascia) to support the urethra. The goal is to see if the donated tissue works as well as your own tissue but avoids an extra incision.
Clermont-FerrandAges 18–85 - NCT06671236RecruitingPhase 1
Treg cell therapy for ALS
This trial tests a new type of cell therapy called regulatory T cells (Tregs) for people with neurodegenerative diseases like ALS. The goal is to see if these cells can slow down the disease.
Zhengzhou, HenanAges 18–70 - NCT06681051Recruiting
OSTENIL TENDON for tendon pain study
This study tests whether OSTENIL TENDON, a gel-like substance injected into the tendon, can safely reduce pain and improve movement in people with common tendon problems (like jumper's knee or tennis elbow). It may be a good option if other treatments haven't worked for you.
Berlin, State of BerlinAges 18–99 - NCT06675617Recruiting
Additional stent for type B aortic dissection treatment
This trial tests a new device, called the Allay aortic stent, that is used along with a standard stent graft to treat a type B aortic dissection (a tear in the aorta). The goal is to improve how the aorta heals and reduce complications. It is for people whose dissection extends into the abdomen and are already planned for stent grafting.
SalzburgAges 18 years+ - NCT06669572RecruitingPhase 2
Lenvatinib and pembrolizumab for advanced anal or rectal cancer
This trial tests a combination of two drugs, lenvatinib and pembrolizumab, for people with anal or rectal cancer that has spread or cannot be removed and has worsened after initial treatment. The goal is to see if this combination can help shrink or control the cancer.
Chicago, IllinoisAges 18 years+ - NCT06680388RecruitingEarly Phase 1
CD19 CAR-T for severe autoimmune diseases
This trial tests whether a special immune cell treatment (CD19 CAR-T) can help people with certain severe autoimmune diseases that have not improved with standard therapies. It is a very early study to see if the treatment is safe and effective for conditions like lupus, systemic sclerosis, vasculitis, myositis, or Sjögren's syndrome.
Tianjin, Tianjin MunicipalityAges 18–65 - NCT06675461Enrolling by invitation
Brief talk therapy for suicidal patients with borderline personality disorder
This trial tests a short talk therapy for people with borderline personality disorder who come to the emergency department after hurting themselves or thinking about suicide. The goal is to see if this brief help can ease suicidal thoughts and keep you safer.
Toronto, OntarioAges 16 years+ - NCT06673329RecruitingPhase 1
Brodalumab for immune-related side effects from cancer treatment
This trial tests if brodalumab, an antibody that blocks a specific immune pathway (IL-17), can help control side effects caused by immunotherapy cancer treatment. It is for people with advanced solid organ cancers who have immune-related side effects that are suspected to involve IL-17.
New York, New YorkAges 18 years+ - NCT06676527Recruiting
Vorolanib for advanced kidney cancer after first treatment
This trial tests a targeted therapy pill, vorolanib, for people with advanced kidney cancer that has clear cell features and has gotten worse after initial treatment. It may offer a new option when standard second-line treatments are not working.
Nanjing, JiangsuAges 18–80 - NCT06679062RecruitingPhase 2
Suvorexant for alcohol use disorder and PTSD
This study tests whether the sleep medication suvorexant can help people with both alcohol use disorder and PTSD. If you're struggling with drinking, PTSD symptoms, and poor sleep, this trial may offer a new treatment option.
Los Angeles, CaliforniaAges 21–65 - NCT06674460RecruitingPhase 3
Edaravone Dexborneol tablet for stroke recovery
This trial tests a new sublingual tablet (Edaravone Dexborneol) to help people recover after a small stroke caused by disease of the small blood vessels in the brain. It aims to see if the drug can improve thinking and daily function.
BeijingAges 30–80 - NCT06672705RecruitingPhase 1
Epcoritamab for lymphoma that returns after an organ transplant
This study tests a drug called epcoritamab for people who have a type of lymphoma that developed after an organ transplant and has not responded to standard treatment. The drug aims to help your immune system fight the cancer cells.
St Louis, MissouriAges 18 years+ - NCT06676501Enrolling by invitation
Second side focused ultrasound for essential tremor
This study tests whether a second focused ultrasound treatment on the other side of the brain can safely and effectively reduce tremor in people with essential tremor who already had one treatment. It's for those whose tremor is not well controlled by medication or previous treatments.
BeijingAges 22 years+
Common questions
- Are there clinical trials studying Treatment A?
- Yes. Clin2 currently lists 8,310 recruiting studies that include Treatment A, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment A trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment A an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment A or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.